Twenty years ago, longevity medicine did not have a name. No standards, no curricula, no consensus on what counted as evidence.
Today, Advanced Research Projects Agency for Health (
@ARPA_H) has committed $144 million through its PROSPR program to develop therapeutics that target the biology of aging directly. The
@xprize Healthspan competition is mobilizing global talent. Governments from Saudi Arabia to the U.S. are funding aging research at unprecedented scale. The field has reached an inflection point.
The field has reached an inflection point. The people building it are gathering in Cambridge on May 26 and 27 for the Aging Code Summit, part of the inaugural Boston Tech Week. I'm speaking on Day 2.
A few of the conversations I'm most looking forward to:
@manoliskellis (MIT) on the computational biology of aging Li-Huei Tsai (The
@MIT_Picower Institute for Learning and Memory) on the latest in neurodegeneration Kristen Fortney
@kpfortney (
@bioagelabs) on translating aging biology into therapeutics Sharon Rosenzweig-Lipson (
@lifebiosciences) on the science behind a leading longevity company
@mahdi_moqri (
@agingbiomarkers Consortium) on where aging clocks are headed Amy Proal, PhD
@microbeminded2 (
@polybioRF Research Foundation) on chronic infection in aging Saranya Wyles, M.D., Ph.D.
@drwyles_derm (Mayo Clinic) on regenerative dermatology and skin longevity Jens Eckstein
@AkikoaCom (Hevolution Foundation
@hevolution_f) on capital meeting the science. My Day 2 talk focuses on evidence-based best practices in longevity medicine, the framework I've been developing across clinical practice, Harvard Medical School teaching, and advisory work with longevity organizations worldwide.
The question I keep returning to: which interventions actually deliver outcomes, and how do we tell. Day 2 also features the pitch competition, where top seed and Series A companies compete for a one-year residency at The Engine, MIT's tough-tech platform and one of the most consequential launchpads in longevity right now.
If you work where this field is being built, you should be in this room. Register:
lnkd.in/eYZX5NH2
Joining an extraordinary faculty including Christin Glorioso MD PhD
@DrGlorioso (NeuroAge Therapeutics
@NeuroAgeTX),
@JamieHeywood (
@AldenScientific), Fiona Miller (
@quadrascope),
@Dr_RayMak, José Navarro Betancourt, MD, PhD, Justin Taylor, Noriko Yokoi, Ph.D., Daniel Dacey, SpringBehrouz, Raghav Sehgal, PhD
@rv_sehgal, Jay Luthar, MD, DipABLM,
@HillaryLinMD, Umbereen S. Nehal, MD, MPH, MBA
@usnehal,
@tomzuber, Robin Mansukhani, Fernanda Cerqueira, David Hall, Yeh-Chuin Poh, Salah Mahmoudi, and
@RutaLaukien
Updates at:
linkedin.com/in/agingdoc
More at
linkedin.com/in/agingdoc #BostonTechWeek #LongevityMedicine